Physician profile
Eugen Stancut
NPI 1356508352
$2,253.23
in general payments reported to CMS, 2019-2025
16 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,088 · 2020: $328 · 2021: $305 · 2022: $51.02 · 2023: $16.51 · 2024: $132 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $415.86 | 2019-2025 | Cabtreo |
| Allergan, INC. | $371.32 | 2019-2022 | |
| Galderma Laboratories, L.P. | $360.61 | 2019-2022 | |
| Genzyme Corporation | $237.41 | 2019-2025 | |
| Lilly USA, LLC | $171.55 | 2020-2023 | Taltz, Olumiant |
| Abbvie INC. | $157.69 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $149.83 | 2025 | Tremfya |
| Dermira, INC. | $125.00 | 2019 | |
| Incyte Corporation | $55.72 | 2021-2025 | Opzelura |
| Regeneron Pharmaceuticals, INC. | $45.00 | 2019 | |
| Kerecis Limited | $34.36 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Novartis Pharmaceuticals Corporation | $31.72 | 2025 | |
| Organogenesis INC. | $28.06 | 2025 | Affinity |
| Leo Pharma INC. | $27.83 | 2025 | Adbry |
| Mimedx Group, INC. | $25.30 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugen Stancut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.